Orthocell Ltd (ASX: OCC) is today celebrating the lifelong achievements of Professor Lars Lidgren, a Swedish surgeon, researcher, entrepreneur and Orthocell board member, who has been awarded an honorary fellowship by the American College of Surgeons (ACS).
Channel 9 News has featured Orthocell’s Ortho-ATI™ as part of its nightly news coverage.
Orthocell has been featured in the Weekend Australian this week as one of two Perth companies transforming the state’s economic reliance on mining.
Positive results from Orthocell’s study into its novel tendon cell therapy treatment for tennis elbow have been featured in Small Caps.
Small Caps has reported on a successful clinical study showing our CelGro™ medical device improves dental bone regeneration.
News that Orthocell has been granted a key Canadian patent for our Ortho-ATI product has been published in Small Caps.
Orthcell CEO and Managing Director, Paul Anderson, speaks with CommSec’s Tom Piotrowski about the company’s two key products, its recently received CE Mark approval for its CelGro™ product and its plans for commercialisation in FY18.
What university student would give up their hard-earned summer, leave their friends to vacation on the beach to move to the opposite hemisphere for the coldest weeks of winter to work as an intern? Penn State University biomedical engineering undergraduate student, Margaux Steltz would. And very happily.
Orthocell CEO & Managing Director, Paul Anderson, explains the unique technology behind the company’s cellular regenerative medicine, and in particular how its collagen-based scaffold is different to other collagen therapies.
Orthocell has been featured in The Australian following news of securing a US patent for our “cell factory” technology.